Balanced news tone
News Sentiment
PAVM sentiment intelligence
PAVmed Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
62 relevant articles
News tone and price action are not far from neutral.
74/100 classification confidence.
directly relevant articles
high-authority source matches
-1.9% over one week, +12.0% over four weeks, trend inactive, and below fair value.
Price to book forward of PAVmed Inc. – NASDAQ:PAVM
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Earnings
74/100 classification
One-week reaction
-1.9%
Price digesting
Trend fit
Trend inactive
12.0% over four weeks
Fair value
-86.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
9
Neutral
44
Negative
9
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Industry context
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
TradingView
Direct company coverage
Price to book forward of PAVmed Inc. – NASDAQ:PAVM
The article focuses on the "Price to book forward" financial metric for PAVmed Inc. (NASDAQ: PAVM). It appears to be a financial data page from TradingView, providing an overview of this specific valuation ratio for the company.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 08:43
- Source
- TradingView
TradingView
Direct company coverage
Price to sales forward of PAVmed Inc. – NASDAQ:PAVM
This page provides financial information for PAVmed Inc. (NASDAQ: PAVM) on TradingView, specifically focusing on the company's forward price to sales ratio. It lists the stock on the Nasdaq Stock Market and appears to be a stub or an incomplete data presentation, indicating "No t
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 10:41
- Source
- TradingView
TradingView
Direct company coverage
Price to earnings forward of PAVmed Inc. – NASDAQ:PAVM
The article focuses on the "Price to earnings forward" metric for PAVmed Inc. (NASDAQ: PAVM). It appears to be a financial data snippet from TradingView, indicating that the market for PAVM is currently closed with no trades recorded.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 00:39
- Source
- TradingView
MSN
Direct company coverage
PAVmed gets 180-day extension to regain Nasdaq listing compliance
PAVmed has been granted a 180-day extension by Nasdaq to regain compliance with its listing requirements. This extension provides the medical device company additional time to meet the necessary criteria to maintain its listing on the exchange. The news indicates a temporary repr
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 06:39
- Source
- MSN
TradingView
Direct company coverage
PAVmed, Inc. Financial Disclosures & Filings
This article provides a comprehensive list of PAVmed, Inc.'s financial disclosures and regulatory filings, organized by fiscal year and quarter. It includes links to earnings call transcripts, earnings releases, quarterly and annual reports (10-Q and 10-K), and presentation slide
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 03 Jul 2026 07:10
- Source
- TradingView
TradingView
Direct company coverage
Enterprise value to revenue forward of PAVmed Inc. – NASDAQ:PAVM
This article provides an overview of PAVmed Inc. (NASDAQ: PAVM) focusing on its enterprise value to revenue forward metric. It appears to list financial data and market information through the TradingView platform. The content is primarily a listing of financial data access rathe
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jul 2026 08:11
- Source
- TradingView
www.marketscreener.com
Direct company coverage
PAVmed Inc.(NasdaqCM: PAVM) added to Russell Microcap Value Benchmark Index
PAVmed Inc. (NasdaqCM: PAVM), a commercial-stage medical technology company, has been added to the Russell Microcap Value Benchmark Index. This inclusion follows its prior addition to the Russell 3000E Index and the Russell Microcap Index. The company operates in medical devices,
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 29 Jun 2026 13:14
- Source
- www.marketscreener.com
marketscreener.com
Direct company coverage
PAVmed Inc.(NasdaqCM: PAVM) added to Russell 3000E Value Benchmark
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 07:00
- Source
- marketscreener.com
TradingView
Direct company coverage
PAVmed, Inc. Actuals & Estimates (NASDAQ:PAVM)
This article provides an overview of PAVmed Inc. (NASDAQ: PAVM) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, financial actuals and estimates, upcoming earnings dates, and past earnings and revenue figures. Th
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 26 Jun 2026 03:40
- Source
- TradingView
TradingView
Direct company coverage
PAVM Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for PAVmed Inc. (PAVM) stock for 2027, based on analyst opinions. It details the current stock price, historical performance, volatility, market capitalization, and upcoming earnings report. The article also includes frequently as
- Tone
- Negative 18/100
- Event
- Analyst action
- Published
- 25 Jun 2026 14:40
- Source
- TradingView
Stock Titan
Direct company coverage
PAVmed (PAVM) holders re-elect directors, expand ESPP shares and ratify CBIZ
PAVmed Inc. shareholders re-elected directors Ronald M. Sparks and Timothy Baxter and approved significant amendments to the Employee Stock Purchase Plan (ESPP), increasing available shares and the annual evergreen limit. Additionally, shareholders ratified CBIZ CPAs P.C. as the
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 24 Jun 2026 21:09
- Source
- Stock Titan
TradingKey
Direct company coverage
PAVmed Inc (PAVM) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of PAVmed Inc (PAVM), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock has a current price momentum score of 7.15 and is trading between a resistance level of 6.
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 23 Jun 2026 07:39
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVM) Financial Health: Profitability & Balance Sheet Analysis
This article analyzes the financial health of PAVmed Inc (PAVM), noting its stable financial status but low operational efficiency. As of June 18, 2026, its financial score is 7.21, ranking 101 out of 203 in the Healthcare Equipment & Supplies industry. The company reported a sig
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 19 Jun 2026 11:10
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVMZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of PAVmed Inc (PAVMZ), covering its support, resistance, indicators, and moving averages. It notes that relevant data for support and resistance have not yet been disclosed by the company. The analysis indicates a "Sell" signal based on
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 23:40
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVM) Institutional Confidence
This article provides details on PAVmed Inc (PAVM)'s institutional confidence, highlighting its stock price, market cap, and a breakdown of its TradingKey Stock Score, which includes institutional confidence. It lists key institutional shareholders and their shareholdings. The da
- Tone
- Positive 59/100
- Event
- Market update
- Published
- 18 Jun 2026 23:39
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVMZ) Financial Health: Profitability & Balance Sheet Analysis
This article provides an analysis of PAVmed Inc's (PAVMZ) financial health, focusing on profitability and its balance sheet. However, the report indicates that relevant financial data for key metrics such as cash and cash equivalents, total assets, liabilities, free cash flow, re
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 18 Jun 2026 22:40
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVM) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of PAVmed Inc's (PAVM) dividend history and stock split events. It indicates that PAVmed has not distributed any dividends in the past five years. The article also lists several stock split events, all described as "Merger" type, with the most re
- Tone
- Negative 40/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 22:40
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVM) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of PAVmed Inc (PAVM), listing major individual and institutional holders and their respective proportions. It also presents a historical overview of institutional shareholding by reporting period, as well as recent shareholder activi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 15:39
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVM) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for PAVmed Inc (PAVM), detailing its current earnings forecast score, analyst ratings, and price targets. It notes that PAVmed Inc has an earnings forecast score of 8.00, ranks 66th in its industry, and has an average price target of $12
- Tone
- Positive 65/100
- Event
- Earnings
- Published
- 18 Jun 2026 12:39
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article from TradingKey attempts to provide a revenue breakdown for PAVmed Inc (PAVM) by business segments and regional contributions. However, the company has not disclosed the relevant financial data. Therefore, the article primarily highlights the unavailability of this s
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 08:39
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVMZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
The article discusses the revenue breakdown of PAVmed Inc (PAVMZ) but explicitly states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. Therefore, the content highlights the lack of publicly ava
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 15:10
- Source
- TradingKey
TradingKey
Direct company coverage
PAVmed Inc (PAVMZ) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides an overview of PAVmed Inc's (PAVMZ) shareholder structure, highlighting that "Other" shareholders account for 100% of the proportional holdings. It also details institutional shareholding data from Q3 2023 to Q3 2025, showing changes in the number of institu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:10
- Source
- TradingKey
Market source
Industry context
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 07:00
- Source
- Market source
GuruFocus
Direct company coverage
PAVM Maintains Buy Rating -- Price Target Lowered to $56.00 by Ascendiant Capital
Ascendiant Capital has maintained a "Buy" rating for PAVmed Inc (PAVM) but lowered its price target from $65.00 to $56.00, representing a 13.85% decrease. Despite the maintained buy rating, GuruFocus indicates that PAVM is significantly overvalued with a GF Value™ of $1.28 agains
- Tone
- Negative 38/100
- Event
- Analyst action
- Published
- 08 Jun 2026 10:39
- Source
- GuruFocus
Finviz
Direct company coverage
PAVM - PAVmed Inc Stock Price and Quote
This article provides comprehensive stock information for PAVmed Inc. (PAVM), including its current stock price, financial metrics, performance indicators, and recent news and analyst ratings. It also details the company's business activities, focusing on its Lucid Diagnostics an
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 02 Jun 2026 16:39
- Source
- Finviz
Market source
Direct company coverage
How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 01 Jun 2026 07:00
- Source
- Market source
dars.gov.et
Direct company coverage
PAVmed Inc. (PAVM) Holds Steady Near Support as Slight Dip Signals Consolidation - Intraday Profile
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- dars.gov.et
Intellectia AI
Direct company coverage
PAVM Technical Analysis & Stock Price Forecast
This article provides a technical analysis of PAVmed Inc (PAVM), concluding with a "Strong Sell" consensus based on various indicators. It details moving averages, momentum indicators like RSI and MACD, and identifies key support and resistance levels. The analysis highlights tha
- Tone
- Negative 8/100
- Event
- Guidance
- Published
- 28 May 2026 01:38
- Source
- Intellectia AI
Intellectia AI
Direct company coverage
PAVM PE Ratio & Valuation, Is PAVM Overvalued
This article analyzes the valuation of PAVmed Inc (PAVM), concluding that it is currently overvalued. Based on relative valuation methods, PAVM's fair price is estimated to be between $2.40 and $5.27, compared to its current price of $6.35, indicating a 20.39% overvaluation. The
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 22 May 2026 19:09
- Source
- Intellectia AI